Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.

José Meneses CalderónHugo Mendieta ZerónSrivatsan Padmanabhan

Published in: Trials (2020)

ClinicalTrials.gov Identifier: NCT04341493. Date of trial registration: April 10, 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.

Keyphrases

poor prognosis
randomized controlled trial
long non coding rna
coronavirus disease
sars cov
study protocol
clinical trial
combination therapy
open label